Literature DB >> 17071057

Structural analysis of the basal ganglia in schizophrenia.

Daniel Mamah1, Lei Wang, Deanna Barch, Gabriel A de Erausquin, Mokhtar Gado, John G Csernansky.   

Abstract

Increases in the total volume of basal ganglia structures have been reported in schizophrenia. However, patterns of basal ganglia shape change, which can reveal localized changes in substructure volumes, have not been investigated. In this study, the total volume and shape of several basal ganglia structures were compared in subjects with and without schizophrenia. T(1)-weighted magnetic resonance scans were collected in 54 schizophrenia and 70 comparison subjects. High-dimensional (large-deformation) brain mapping was used to assess the shape and volume of several basal ganglia structures. The relationships of shape and volume measures with psychopathology, cognition and motor function were also assessed. Left and right volumes of the caudate and putamen, as well as the right globus pallidus volume, were significantly increased in subjects with schizophrenia as compared to comparison subjects after total brain volume was included as a covariate. Significant differences in shape accompanied these volume changes in the caudate, putamen and globus pallidus, after their total volumes were included as covariates. There were few significant correlations between volume or shape measures and either cognitive function or clinical symptoms, other than a positive correlation between an attention/vigilance cognitive dimension and the volume of the caudate and putamen, and a negative correlation between nucleus accumbens volume and delusions. In conclusion, basal ganglia volumes relative to total brain volume were larger in schizophrenia subjects than healthy comparison subjects. Specific patterns of shape change accompanied these volume differences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071057      PMCID: PMC1839817          DOI: 10.1016/j.schres.2006.08.031

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

1.  Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

Authors:  Handan Gunduz; Huwei Wu; Manzar Ashtari; Bernhard Bogerts; David Crandall; Delbert G Robinson; Jose Alvir; Jeffrey Lieberman; John Kane; Robert Bilder
Journal:  Biol Psychiatry       Date:  2002-05-15       Impact factor: 13.382

Review 2.  A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.

Authors:  Dennis J Zgaljardic; Joan C Borod; Nancy S Foldi; Paul Mattis
Journal:  Cogn Behav Neurol       Date:  2003-12       Impact factor: 1.600

3.  Abnormalities of thalamic volume and shape in schizophrenia.

Authors:  John G Csernansky; Mathew K Schindler; N Reagan Splinter; Lei Wang; Mohktar Gado; Lynn D Selemon; Devna Rastogi-Cruz; Joel A Posener; Paul A Thompson; Michael I Miller
Journal:  Am J Psychiatry       Date:  2004-05       Impact factor: 18.112

4.  The assessment and analysis of handedness: the Edinburgh inventory.

Authors:  R C Oldfield
Journal:  Neuropsychologia       Date:  1971-03       Impact factor: 3.139

5.  Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping.

Authors:  John G Csernansky; Lei Wang; Donald Jones; Devna Rastogi-Cruz; Joel A Posener; Gitry Heydebrand; J Philip Miller; Michael I Miller
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

6.  Attention disorders in schizophrenia.

Authors:  Hiroshi Suwa; Eisuke Matsushima; Katsuya Ohta; Katsumi Mori
Journal:  Psychiatry Clin Neurosci       Date:  2004-06       Impact factor: 5.188

7.  Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs.

Authors:  Candace Andersson; Robert M Hamer; Cindy P Lawler; Richard B Mailman; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2002-08       Impact factor: 7.853

8.  Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.

Authors:  Donna J Lang; Lili C Kopala; Robert A Vandorpe; Qing Rui; Geoffrey N Smith; Vina M Goghari; Jocelyne S Lapointe; William G Honer
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

9.  Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.

Authors:  Pedro Rosa-Neto; Doris J Doudet; Paul Cumming
Journal:  Neuroimage       Date:  2004-07       Impact factor: 6.556

10.  Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans.

Authors:  Stéphane Lehéricy; Mathieu Ducros; Pierre-François Van de Moortele; Chantal Francois; Lionel Thivard; Cyril Poupon; Nick Swindale; Kamil Ugurbil; Dae-Shik Kim
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

View more
  55 in total

Review 1.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

2.  Early life stress and trauma and enhanced limbic activation to emotionally valenced faces in depressed and healthy children.

Authors:  Hideo Suzuki; Joan L Luby; Kelly N Botteron; Rachel Dietrich; Mark P McAvoy; Deanna M Barch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-05-10       Impact factor: 8.829

3.  Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder.

Authors:  Fay Y Womer; Lei Wang; Kathryn I Alpert; Matthew J Smith; John G Csernansky; Deanna M Barch; Daniel Mamah
Journal:  Psychiatry Res       Date:  2014-06-06       Impact factor: 3.222

4.  Northwestern University schizophrenia data sharing for SchizConnect: A longitudinal dataset for large-scale integration.

Authors:  Alex Kogan; Kathryn Alpert; Jose Luis Ambite; Daniel S Marcus; Lei Wang
Journal:  Neuroimage       Date:  2015-06-16       Impact factor: 6.556

5.  Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment.

Authors:  E Zampieri; M Bellani; B Crespo-Facorro; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-22       Impact factor: 6.892

6.  Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia.

Authors:  Lei Wang; Daniel Mamah; Michael P Harms; Meghana Karnik; Joseph L Price; Mokhtar H Gado; Paul A Thompson; Deanna M Barch; Michael I Miller; John G Csernansky
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

7.  Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia.

Authors:  Martina Ballmaier; Florian Schlagenhauf; Arthur W Toga; Jürgen Gallinat; Michael Koslowski; Michele Zoli; Cornelius Hojatkashani; Katherine L Narr; Andreas Heinz
Journal:  Schizophr Res       Date:  2008-09-24       Impact factor: 4.939

Review 8.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

9.  The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis.

Authors:  Ian Ellison-Wright; David C Glahn; Angela R Laird; Sarah M Thelen; Ed Bullmore
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

10.  DTNBP1 is associated with imaging phenotypes in schizophrenia.

Authors:  Katherine L Narr; Philip R Szeszko; Todd Lencz; Roger P Woods; Liberty S Hamilton; Owen Phillips; Delbert Robinson; Katherine E Burdick; Pamela DeRosse; Raju Kucherlapati; Paul M Thompson; Arthur W Toga; Anil K Malhotra; Robert M Bilder
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.